Three U-M researchers receive Taubman Emerging Scholars grants
Three young physician-scientists whose research shows extraordinary promise have been appointed to the Emerging Scholars Program at the University of Michigan’s A. Alfred Taubman Medical Research Institute.
The Emerging Scholars Program was created to support and encourage early-career physician-scientists whose laboratory work aims to translate basic research into new treatments for disease.
The program connects U-M Medical School faculty members at the assistant professor level with philanthropists who pledge to support the physicians’ research for three years at $50,000 per year. This support enables the young scientists to establish the credentials necessary to pursue more traditional means of funding and keeps them from dropping out of the research arena for a variety of reasons.
Clinician-scientists are uniquely positioned to translate laboratory findings into therapies for patients, but the average physician-researcher does not achieve initial National Institutes of Health funding until age 44. Many talented researchers are lost in the interim to more lucrative clinical practices or other pursuits, and with them the research world loses the promise of medical breakthroughs.
“We urgently need the best and brightest doctors, who are so motivated by the patient suffering they witness each day, to continue to develop new therapies,” says Eva Feldman, M.D., Ph.D., director of the Taubman Institute.
The new Taubman Emerging Scholars are:
- Katherine Gallagher, M.D., Assistant Professor of Surgery. Gallagher studies impaired wound healing in diabetes patients, particularly the role of inflammation and immune cell function. She has been named the Friends of Judy and Alfred Taubman Emerging Scholar.
- Alon Kahana, M.D., Ph.D., Assistant Professor and Helmut F. Stern Career Development Professor of Ophthalmology and Visual Sciences. Kahana’s laboratory work studies the use of stem cells to regenerate eye tissue lost to injury or disease. He has been named the Mrs. William Davidson Emerging Scholar.
- Parag Patil, M.D., Ph.D., Assistant Professor of Neurosurgery, Anesthesiology and Biomedical Engineering. Dr. Patil, who also trained as an engineer, studies the use of deep-brain stimulation to treat neurological and psychiatric diseases. He has been named the Young Friends of the Taubman Institute Emerging Scholar.
These grants bring the current total of Taubman Emerging Scholars to seven.
“The Emerging Scholar grant plays a critical role for young clinician-scientists early in their careers so that they can lay the foundation for future scientific endeavors in translational research,” says Gallagher. “It provides me with the resources necessary to pursue my research and to develop new and innovative treatments for patients suffering from diabetes.”
Patil’s appointment marks the first time a volunteer group has collected funds to support a scholar. The Young Friends of the Taubman Institute was established to raise awareness among the next generation of biomedical research and the work of the Taubman Institute. Its 15 board members and some 200 members, in Michigan and New York chapters, share the institute’s mission with other young professionals. In May, the group held a fundraising reception in Manhattan and selected Patil as its scholar.
“The Young Friends’ support of an Emerging Scholar is a unique commitment and one that we are so pleased to accept,” says Feldman. “It is so heartening that the next generation of young leaders has taken an interest in translational medical research, and their efforts show that even people early in their philanthropic careers can make a true difference by pooling their resources in this novel way.
“We are thrilled at their interest and support, and we also sincerely thank all of our Emerging Scholars donors for taking part in keeping brilliant young minds in the research labs.”
The Taubman Institute has identified a number of other candidates for Emerging Scholars grants, in fields ranging from cardiology to cancer to obesity and is actively working to match them with donors. Candidates are nominated by Taubman Scholars or the chairs of their medical school departments and are vetted by the Taubman Institute’s Scientific Advisory Board. Applications for Taubman Emerging Scholars grants are accepted via the institute’s website at www.taubmaninstitute.org.
Previously appointed Taubman Emerging Scholars are:
Ronald J. Buckanovich, M.D., Ph.D.
Marvin and Betty Danto Family Foundation Emerging Scholar
Assistant Professor of Internal Medicine and of Obstetrics and Gynecology
James J. Dowling, M.D., Ph.D.
Frances and Kenneth Eisenberg Emerging Scholar
Assistant Professor of Pediatrics and Communicable Diseases and Neurology
Johann E. Gudjonsson, M.D., Ph.D.
Frances and Kenneth Eisenberg Emerging Scholar
Assistant Professor of Dermatology
Erika A. Newman, M.D.
Edith S. Briskin/SKS Foundation Emerging Scholar
Assistant Professor of Pediatric Surgery
Click here to view a video about the Taubman Emerging Scholars Program.
Taubman Science
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
Click here to read the interview
Clinical Trials
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Taubman Science
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman Institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
The Latest
-
Dr. Eva Feldman discusses stem cell therapies on Michigan Radio
June 14, 2013 -
2013 Taubman Prize
June 05, 2013 -
Stem cell treatment "dramatically slows ALS" in some patients
May 31, 2013
Taubman Science
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
Accomplishments
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.




Donors pitch in to keep brilliant science minds at U-M Video